CP1
Click for more information
0.00% 17.0¢ cannpal animal therapeutics limited

Ann: CannPal Enters into Research Agreement with Eurofins, page-4

  1. Furiousgeorge
    5,925 Posts.
    lightbulb Created with Sketch. 414
    clock Created with Sketch.
    04/07/18
    12:26
    Post #: 34131615
    Can anyone who knows the market better than me , shed any light on why so many are bailing from this share and dragging the price down?
    I’m not experienced at all at this but this would seem to be an organisation to keep hold of
    CP1 Price at posting: 19.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.